Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 9.75
-1.25 (-11.36%)
At close: Aug 28, 2026
Devonian Health Group Cash Flow Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Net Income | -6.11 | -6.01 | -1.83 | -4.6 | -3.45 | -3.35 |
Depreciation & Amortization | 0.21 | 0.35 | 0.43 | 0.42 | 0.85 | 1.02 |
Other Amortization | - | 0.08 | - | 0.01 | 0.02 | 0.01 |
Asset Writedown & Restructuring Costs | - | 4.84 | 0.24 | - | - | - |
Stock-Based Compensation | 1.45 | 0.69 | 0.73 | 0.48 | 0.53 | 0.08 |
Other Operating Activities | -0.42 | 0.01 | 0.01 | -0.35 | -0.22 | 0.78 |
Change in Accounts Receivable | 5.2 | 6.83 | -7.1 | -0.55 | -0.1 | 0.29 |
Change in Inventory | 0.04 | 0.03 | 0.1 | -0.01 | -0.13 | 0.06 |
Change in Accounts Payable | -11.19 | -7.25 | 12.52 | 0.35 | -0.31 | -0.89 |
Change in Income Taxes | -0.81 | -0.81 | 0.85 | - | - | - |
Change in Other Net Operating Assets | 0.08 | 0.21 | -0.23 | -0.11 | -0.07 | 0.15 |
Operating Cash Flow | -11.77 | -1.25 | 5.64 | -4.36 | -2.87 | -1.83 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Capital Expenditures | -0.01 | -0.02 | -0 | - | -0.07 | - |
Investment in Securities | - | - | - | 5 | -5 | - |
Other Investing Activities | - | - | - | - | -0.01 | -0.01 |
Investing Cash Flow | -0.01 | -0.02 | -0 | 5 | -5.08 | -0.01 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Long-Term Debt Issued | - | - | 2.08 | - | - | 0.06 |
Total Debt Issued | 0.18 | - | 2.08 | - | - | 0.06 |
Long-Term Debt Repaid | - | -2.21 | -3.62 | -0.31 | -0.53 | -0.01 |
Total Debt Repaid | -0.07 | -2.21 | -3.62 | -0.31 | -0.53 | -0.01 |
Net Debt Issued (Repaid) | 0.11 | -2.21 | -1.55 | -0.31 | -0.53 | 0.05 |
Issuance of Common Stock | 2.62 | 0.6 | 0.71 | 1.93 | 10.94 | 1.23 |
Financing Cash Flow | 2.73 | -1.61 | -0.84 | 1.61 | 10.41 | 1.28 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Net Cash Flow | -9.04 | -2.88 | 4.8 | 2.26 | 2.46 | -0.57 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Free Cash Flow | -11.77 | -1.27 | 5.64 | -4.36 | -2.95 | -1.83 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -393.06% | -5.36% | 29.20% | -185.74% | -127.77% | -124.31% |
Free Cash Flow Per Share | -4.36 | -0.51 | 2.30 | -1.93 | -1.49 | -1.24 |
Levered Free Cash Flow | -9.57 | -0.74 | 6.55 | -2.53 | -2.14 | -1.14 |
Unlevered Free Cash Flow | -9.55 | -0.67 | 6.83 | -2.24 | -1.56 | -0.64 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Cash Interest Paid | - | 0.13 | 0.36 | 0.43 | 0.31 | 0.3 |
Change in Working Capital | -6.89 | -1.2 | 6.06 | -0.32 | -0.6 | -0.39 |